Sarcoma Metabolomics: Current Horizons and Future Perspectives

被引:10
|
作者
Esperanca-Martins, Miguel [1 ,2 ,3 ]
Fernandes, Isabel [1 ,3 ,4 ]
Soares do Brito, Joaquim [4 ,5 ]
Macedo, Daniela [6 ]
Vasques, Hugo [4 ,7 ]
Serafim, Teresa [2 ]
Costa, Luis [1 ,3 ,4 ]
Dias, Sergio [2 ,4 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Med Oncol Dept, P-1649028 Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Vasc Biol & Canc Microenvironm Lab, P-1649028 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Translat Oncobiol Lab, P-1649028 Lisbon, Portugal
[4] Univ Lisbon, Fac Med, P-1649028 Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Orthoped & Traumatol Dept, P-1649028 Lisbon, Portugal
[6] Hosp Lusiadas Lisboa, Med Oncol Dept, P-1500458 Lisbon, Portugal
[7] Inst Portugues Oncol Francisco Gentil, Gen Surg Dept, P-1099023 Lisbon, Portugal
关键词
sarcoma; soft tissue sarcoma; bone sarcoma; gastrointestinal stromal tumor; metabolomics; metabolism; SOFT-TISSUE SARCOMA; IN-VITRO; CELL-LINES; CANCER; OSTEOSARCOMA; TUMORS; METABOLISM; INHIBITORS; HALLMARKS; PATHWAY;
D O I
10.3390/cells10061432
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The vast array of metabolic adaptations that cancer cells are capable of assuming, not only support their biosynthetic activity, but also fulfill their bioenergetic demands and keep their intracellular reduction-oxidation (redox) balance. Spotlight has recently been placed on the energy metabolism reprogramming strategies employed by cancer cells to proliferate. Knowledge regarding soft tissue and bone sarcomas metabolome is relatively sparse. Further characterization of sarcoma metabolic landscape may pave the way for diagnostic refinement and new therapeutic target identification, with benefit to sarcoma patients. This review covers the state-of-the-art knowledge on cancer metabolomics and explores in detail the most recent evidence on soft tissue and bone sarcoma metabolomics.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Environmental metabolomics: a critical review and future perspectives
    Jacob G. Bundy
    Matthew P. Davey
    Mark R. Viant
    Metabolomics, 2009, 5
  • [42] Immunotherapeutic strategies for sarcoma: current perspectives
    Li, Xueyao
    Wang, Gangyang
    Cai, Zhengdong
    Sun, Wei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (12): : 7693 - 7701
  • [43] Metabolomics in Breast Cancer: Current Status and Perspectives
    Hart, Christopher D.
    Tenori, Leonardo
    Luchinat, Claudio
    Di Leo, Angelo
    NOVEL BIOMARKERS IN THE CONTINUUM OF BREAST CANCER, 2016, 882 : 217 - 234
  • [44] The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives
    Fiore, Michele
    Sambri, Andrea
    Spinnato, Paolo
    Zucchini, Riccardo
    Giannini, Claudio
    Caldari, Emilia
    Pirini, Maria Giulia
    De Paolis, Massimiliano
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (12)
  • [45] Recent advances in single-cell metabolomics using mass spectrometry: emerging challenges and future perspectives
    Alam, Rafiqul
    Lee, Jung-Hyun
    Shin, Doyun
    Choi, Il-Kyu
    Kim, Sunghwan
    Lim, Heejin
    Kim, Min-Sik
    APPLIED SPECTROSCOPY REVIEWS, 2025,
  • [46] Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
    Peng, Yan
    Mei, Wuxuan
    Ma, Kaidong
    Zeng, Changchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Lipid-targeting antiviral strategies: Current state and future perspectives
    Blazquez, Ana-Belen
    Mingo-Casas, Patricia
    Quesada, Ernesto
    Priego, Eva Maria
    Perez-Perez, Maria-Jesus
    Martin-Acebes, Miguel A.
    ANTIVIRAL RESEARCH, 2025, 236
  • [48] Desmoid-type fibromatosis: Current therapeutic strategies and future perspectives
    Ibrahim, Rebecca
    Assi, Tarek
    Khoury, Rita
    Ngo, Carine
    Faron, Matthieu
    Verret, Benjamin
    Levy, Antonin
    Honor, Charles
    Henon, Clemence
    Le Pechoux, Cecile
    Bahleda, Ratislav
    Le Cesne, Axel
    CANCER TREATMENT REVIEWS, 2024, 123
  • [49] Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future
    Simunic, Marin
    Mcgraw, Kathy
    Pavletic, Steven Z.
    Rashidi, Armin
    SEMINARS IN HEMATOLOGY, 2024, 61 (06) : 442 - 448
  • [50] The future of immunotherapy for sarcoma
    Tsukahara, Tomohide
    Emori, Makoto
    Murata, Kenji
    Mizushima, Emi
    Shibayama, Yuji
    Kubo, Terufumi
    Kanaseki, Takayuki
    Hirohashi, Yoshihiko
    Yamashita, Toshihiko
    Sato, Noriyuki
    Torigoe, Toshihiko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (08) : 1049 - 1057